Seema Verma, administrator of the Centers for Medicare and Medicaid Services. Photo: White House/flickr
Less than a month away from the November election, Trump administration officials are reportedly rushing to implement the president’s recent proposal to send $200 prescription drug discount cards to nearly 40 million Medicare recipients—an $8 billion plan that would be financed by dipping into the Medicare trust fund.
Politicoreported Thursday that the administration is “seeking to finalize the plan as soon as Friday and send letters to 39 million Medicare beneficiaries next week, informing seniors of Trump’s new effort to lower their drug costs, although many seniors would not receive the actual cards until after the election.” While the design of the cards has yet to be finalized, officials are reportedly discussing ways to put Trump’s name on them. Continue reading →
Ethics watchdogs on Wednesday slammed a ruling by the Health and Human Services Department’s inspector general, who decided this week that Moncef Slaoui, a former pharmaceutical executive now heading the Trump administration’s coronavirus vaccine task force, does not have to disclose or divest his investments in the industry.
As the co-director of Operation Warp Speed, a public-private partnership aimed at finding a vaccine for Covid-19 by the end of 2020, Slaoui is in the position to award contracts to pharmaceutical companies researching potential vaccines and treatments. Continue reading →